Sponsor Pipeline

Zhigang Li Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05043688 Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy… Resectable Esophageal Squamous Cell Carcinoma Recruiting
Phase 2
NCT06861894 Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for… Esophageal Squamous Cell Carcinoma Not Yet Recruiting
NCT07524374 SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC… ESCC Not Yet Recruiting
Get alerts when Zhigang Li's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free